Entrepreneur, Klodian Allajbeu, has reacted after statements made regarding the hemodialysis service and the mention of his name as a possible beneficiary of future procedures, denying any interest of his or his related companies in this process.

In his reaction, responding to the DP, Allajbeu describes the period when he was involved in the hemodialysis concession as a success story, emphasizing investments in infrastructure, equipment and personnel training, which according to him made it possible to provide the service near patients' homes and according to international standards.

However, he points out that for more than eight years the concession has been sold and has passed into the ownership and management of the Swedish company Diaverum, which he describes as one of the largest European operators in the field of hemodialysis.

"Since the moment of sale, I personally and no company associated with me have had and do not have any ownership, economic interest, administrative role or involvement in the management of this concession," Allajbeu said.

Referring to the new procedure for providing hemodialysis services, he states that neither he nor his affiliated companies have any interest in participating in any competition procedure, currently or in the future.

For this reason, Allajbeu considers the DP's allusions that the upcoming procedure may have him, the American Hospital, or companies affiliated with it as beneficiaries as unfounded.

He emphasizes that the debate on the organization of hemodialysis services, costs, procurement criteria, and transparency of procedures is legitimate, but according to him, it should be based on documents and facts.

Klodian Allajbeu's full reaction;

Regarding the statements made today about the hemodialysis service and the mention of my name as a potential beneficiary of future procedures, I consider a public clarification necessary.

The hemodialysis concession, during the period I was involved in it, constitutes a success story for the way this service was expanded and modernized in Albania.

Investments in infrastructure and equipment, as well as the training and qualification of personnel, made it possible for patients to receive this vital service close to their homes and according to international standards.

But there is one essential fact that needs to be clarified.

For more than eight years, the concession has been sold and has passed into the ownership and management of Diaverum, a Swedish company and the largest European hemodialysis operator.

Since the moment of sale, I personally and no company affiliated with me have had and do not have any ownership, economic interest, administrative role or involvement in the management of this concession.

I would also like to clarify the issue of the new procedure for hemodialysis services, which has become the subject of debate today.

Neither I nor the companies affiliated with me have any interest and do not intend to participate, now or in the future, in any competition procedure for the provision of this service, which has already passed under the responsibility of OSHIS.

Consequently, any suggestion that the upcoming tender may have me, the American Hospital, or companies affiliated with me as beneficiaries is unfounded.

The debate on how the state will organize the hemodialysis service, costs, procurement procedure criteria, and their transparency is legitimate and should be conducted on documents and facts.

But it is equally important that in this debate, no connections are created with persons or companies that for years have no longer had any economic or administrative interest in the concession and have no interest in the new procedure.

This clarification is made precisely for this reason, to set the facts straight and avoid any misinterpretation or speculation.